Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trial
- 31 August 1998
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 34 (9), 1368-1374
- https://doi.org/10.1016/s0959-8049(98)00068-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Chemotherapy for advanced malignant melanomaInternational Journal of Clinical and Laboratory Research, 1992
- Dacarbazine-Vindesine-Cisplatin in Disseminated Malignant MelanomaAmerican Journal of Clinical Oncology, 1990
- Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatinBritish Journal of Cancer, 1989
- Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A phase II study of the eortc malignant melanoma cooperative groupCancer, 1988
- The Chemotherapy of Human Malignant MelanomaPublished by Springer Science and Business Media LLC ,1983
- Updated results of vindesine as a single agent in the therapy of advanced malignant melanomaCancer Treatment Reviews, 1980
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Integration of chemotherapy into combined modality therapy of solid tumors: IV. Malignant melanomaCancer Treatment Reviews, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958